Drm/gremlin purification from the CM of FGF2-T-MAE cells.
by user
Comments
Transcript
Drm/gremlin purification from the CM of FGF2-T-MAE cells.
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor by Helena Stabile, Stefania Mitola, Emanuela Moroni, Mirella Belleri, Stefania Nicoli, Daniela Coltrini, Francesco Peri, Antonello Pessi, Laura Orsatti, Fabio Talamo, Vincent Castronovo, David Waltregny, Franco Cotelli, Domenico Ribatti, and Marco Presta Blood Volume 109(5):1834-1840 March 1, 2007 ©2007 by American Society of Hematology Drm/gremlin purification from the CM of FGF2-T-MAE cells. Helena Stabile et al. Blood 2007;109:1834-1840 ©2007 by American Society of Hematology rDrm interaction with endothelial cells. Helena Stabile et al. Blood 2007;109:1834-1840 ©2007 by American Society of Hematology rDrm-induced intracellular signaling. Helena Stabile et al. Blood 2007;109:1834-1840 ©2007 by American Society of Hematology Proangiogenic activity of rDrm. Helena Stabile et al. Blood 2007;109:1834-1840 ©2007 by American Society of Hematology Effect of BMP4 on the angiogenic activity of Drm/gremlin. Helena Stabile et al. Blood 2007;109:1834-1840 ©2007 by American Society of Hematology Drm/gremlin expression in tumor xenografts. Helena Stabile et al. Blood 2007;109:1834-1840 ©2007 by American Society of Hematology Drm/gremlin immunohistochemistry in human lung cancers. Helena Stabile et al. Blood 2007;109:1834-1840 ©2007 by American Society of Hematology